Top Biotech Stocks To Buy For 2019

tags:TLT,OPK,BBRY,

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication.

Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.

Sun Pharmaceuticals' biologic approved for plaque psoriasis

Company: Sun Pharmaceuticals (OTCPK:SMPQY)

Therapy: Tildrakizumab-asmn

Disease: Plaque psoriasis

News: Indian pharma SMPQY announced that the FDA has approved their IL-23 antibody tildrakizumab-asmn for the treatment of moderate-to-severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy. This approval was based on the findings from two randomized, placebo-controlled trials showing significant clearance of plaque psoriasis compared with placebo.

Looking forward: With this approval, SMPQY enters a rather crowded field full of effective options for plaque psoriasis, including other therapies targeting interleukins, including the IL-23-directed antibody guselkumab. However, in spite of this rather heavy competition, SMPQY are likely going to be able to make a return on their investment with this approval, and the pie of plaque psoriasis is over $10 billion in the US alone.

Top Biotech Stocks To Buy For 2019: iShares 20+ Year Treasury Bond (TLT)

Advisors' Opinion:

• [By Shane Hupp]

  iShares Barclays 20+ Yr Treas.Bond (NASDAQ:TLT) announced a monthly dividend on Monday, July 2nd, Wall Street Journal reports. Stockholders of record on Tuesday, July 3rd will be given a dividend of 0.2749 per share by the exchange traded fund on Monday, July 9th. This represents a $3.30 annualized dividend and a dividend yield of 2.72%. The ex-dividend date of this dividend is Monday, July 2nd.

• [By Stephan Byrd]

  NEXT Financial Group Inc raised its position in Ishares Lehman 20 Year (NASDAQ:TLT) by 30.0% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 10,785 shares of the exchange traded fund’s stock after acquiring an additional 2,489 shares during the period. NEXT Financial Group Inc’s holdings in Ishares Lehman 20 Year were worth $1,315,000 at the end of the most recent reporting period.

• [By WWW.GURUFOCUS.COM]

  For the details of Nationwide Fund Advisors's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Nationwide+Fund+Advisors

  These are the top 5 holdings of Nationwide Fund AdvisorsiShares Core MSCI Emerging Markets (IEMG) - 4,698,924 shares, 74.25% of the total portfolio. Shares added by 119.53%iShares 20+ Year Treasury Bond ETF (TLT) - 536,574 shares, 17.7% of the total portfolio. Shares added by 79.94%iShares iBoxx $ High Yield Corporate Bond (HYG) - 347,518 shares, 8.05% of the total portfolio. Shares reduced by 20.57%

Top Biotech Stocks To Buy For 2019: Opko Health Inc(OPK)

Advisors' Opinion:

• [By ]

  Opko Health (OPK) : "I've been waiting for these guys to come back on the show and tell us why we should buy."

  International Paper (IP) : "The stock is down big. I say at these prices it's a good buy."

• [By Keith Speights]

  If you're looking for stocks that have made tremendous comebacks in 2018, Opko Health (NASDAQ:OPK) and Myriad Genetics (NASDAQ:MYGN) definitely fit the bill. Opko stock was down nearly 20% this year before roaring back. Myriad Genetics saw its share price plunge close to 40% earlier in 2018, but a strong rebound has the stock price close to where it began the year.�

• [By Lisa Levin] Gainers Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday. ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings. TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday. TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results. Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent. Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results. OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat. Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday. KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings. New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results. Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings. Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Money Morning News Team]

  And after taking a look at our 10 top penny stocks to watch, we'll show you a small-cap stock that just signed a deal with Facebook Inc. (Nasdaq:�FB)…

  Penny Stock Current Share Price Law Week's Gain Blink Charging Co. (Nasdaq: BLNK) $6.00 288.51% Enterprise GP Holdings LP (NYSE: EPE) $2.94 44.00% Opko Health Inc. (Nasdaq: OPK) $4.79 43.49% MYnd Analytics Inc. (Nasdaq: MYND) $3.15 38.84% Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) $0.52 37.80% Mid-Con Energy Partners LP (Nasdaq: MCEP) $2.08 36.81% VAALCO Energy (NYSE: EGY) $1.49 36.04% Cel-Sci Corp. (NYSE: CVM) $3.16 35.04% WideOpenWest Inc. (NYSE: WOW) $8.41 34.52% Legacy Reserves LP (Nasdaq: LGCY) $8.43 33.61%

  While these gains are certainly exciting, it's important to recognize that investing in penny stocks is also a risky investment strategy.

Top Biotech Stocks To Buy For 2019: BlackBerry Limited(BBRY)

Advisors' Opinion:

• [By Shane Hupp]

  BlackBerry (TSE:BB) (NASDAQ:BBRY)‘s stock had its “in-line” rating reiterated by analysts at Imperial Capital in a report issued on Wednesday.